Stress granules in virus infections
Stress granules in virus infections
批准号:
10578897
负责人:
Malathi Krishnamurthy
金额:
$49.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-01-01 至 2025-12-31
关键词:
Antiviral ResponseBindingBiochemicalCellsCellular StressComplexCytoplasmDouble-Stranded RNADrug TargetingEbola virus VP35 proteinEncephalomyocarditis virusEndoribonucleasesEndosomesEukaryotic Initiation FactorsEventFutureG3BP1 geneImmune responseImmune signalingInfectionInnate Immune ResponseInterferonsKnock-outLigandsLigaseMessenger RNAMethodsMolecularMutagenesisNatureOutcomeOxidative StressPathway interactionsPatternPattern recognition receptorPhasePhosphorylationPhysiologicalProductionProtein KinaseProteinsProteomicsRNARNA-Binding ProteinsResistanceRibonucleasesRoleSignal PathwaySignal TransductionStimulusStressStress TestsTestingTimeToll-like receptorsTransfectionTranslationsViralViral PathogenesisViral ProteinsVirusVirus DiseasesWorkbiological adaptation to stressdrug developmentexperimental studyhelicasemutantnew therapeutic targetnoveloligoadenylatepathogenprotein protein interactionreceptorrecruitresponsestress granuletranscriptomicstranslation factorundergraduate researchundergraduate studentvirus host interaction
中文摘要
应激颗粒(stress granule,SG)是由停滞的mRNA、翻译因子、转录因子等组成的非膜性、相分离的复合体
以及响应于不同的应激信号在细胞质中瞬时形成的RNA结合蛋白,
包括病毒感染。在病毒感染期间形成的SG,抗病毒应激颗粒(avSG),不同于
典型的SG,因为它们招募抗病毒蛋白和信号传导途径的成分,作为一种抗病毒蛋白,
建立一个有效的抗病毒反应的平台。然而,其组成、时间变化和功能
病毒感染期间的avSG仍然知之甚少。SG的动态性质表明,宿主细胞使用
avSG作为抗病毒防御的信号中枢。另一方面,病毒已经进化出机制,
拮抗SG的形成和改变SG的用途以促进复制,突出了在病毒中的重要作用。
发病机制SG组成、组装和动力学的应力特异性差异如何影响
病毒感染的结果仍然不清楚,代表了我们对病毒感染的理解的一个关键差距。
信号事件和宿主-病毒相互作用。我们最近的工作突出了avSG作为平台的作用
用于通过dsRNA病原体相关分子模式激活模式识别受体(PRR)
(PAMP)和随后的干扰素(IFN)应答。病毒感染期间产生的DsRNA
感染作为PAMP通过结合胞质Rig-like解旋酶来刺激干扰素(IFN)的产生
(RLH)、内体Toll样受体(TLR)、dsRNA依赖性蛋白激酶(PKR)或2 '-5'寡腺苷酸
合成酶(OAS)。此外,病毒感染诱导病毒和细胞RNA降解的活性,
干扰素诱导核糖核酸内切酶我们最近发现RNase L的dsRNA产物
激活PKR,磷酸化真核生物翻译起始因子-2(eIF 2),
以抑制翻译并诱导avSG形成。我们的结果表明,avSG组件提供了一个
RNA配体与PRR有效相互作用的平台,以增强干扰素产生和抗病毒作用。
我们对这一提议的总体假设是,avSG的组成、组装和拆卸
在病毒感染期间改变,以允许宿主细胞通过限制损伤来响应和清除感染。在
我们的初步研究表明,RNase L的激活诱导了由SG蛋白G3 BP 1标记的avSG的形成
含有抗病毒蛋白Rig-I、PKR、OAS和RNase L。我们开发了一种新的方法来纯化avSG
和生物化学表征的蛋白质-蛋白质相互作用的avSG,将在本提案中使用。我们将
用以下具体目标来检验我们的中心假设。目的1:确定压力特异性差异,
标准SG和avSG中的SG组成,目的2:确定在正常情况下SG的动态变化的生理作用。
病毒感染中的avSG组成。实现这些目标将使我们能够在以下方面取得进展的基础上再接再厉:
纯化avSG以通过遵循组装或拆卸的动力学来剖析SG的抗病毒作用,
分析所述avSG组成以提供应激反应途径和先天信号传导的相关性。
英文摘要
Stress granules (SG) are non-membranous, phase-separated complexes of stalled mRNA, translation factors
and RNA binding proteins that are formed transiently in the cytoplasm in response to diverse stress signals,
including viral infections. SG formed during viral infection, antiviral stress granules (avSG), are distinct from
canonical SG in that they recruit antiviral proteins and components of signaling pathways to function as a
platform to mount an effective antiviral response. However, the composition, temporal changes and function of
avSG during viral infections are still poorly understood. The dynamic nature of SG suggest that host cells use
avSG as a signaling hub for antiviral defense. On the other hand, viruses have evolved mechanisms to
antagonize SG formation and repurpose SG to facilitate replication highlighting an important role in viral
pathogenesis. How the stress-specific differences in SG composition, assembly and dynamics impact
the outcome of viral infections remains unclear and represents a critical gap in our understanding of
signaling events and host-virus interactions. Our recent work has highlighted a role for avSG as a platform
for the activation of pattern recognition receptors (PRRs) by dsRNA pathogen associated molecular patterns
(PAMPs) and subsequent interferon (IFN) response during viral infections. DsRNAs produced during viral
infections serve as PAMPs to stimulate interferon (IFN) production by binding the cytosolic Rig-like helicases
(RLHs), endosomal Toll-like receptors (TLRs), dsRNA-dependent protein kinase (PKR) or 2’-5’oligoadenylate
synthetase (OAS). Furthermore, virus infection induces degradation of viral and cellular RNAs by the activity of
interferon-induced endoribonuclease, RNase L. We have recently shown that dsRNA products of RNase L
activity function as PAMPs and activate PKR, phosphorylate eukaryotic translation initiation factor-2 (eIF2)
to suppress translation and induce avSG formation. Our results demonstrate that avSG assembly provides a
platform for efficient interaction of RNA ligands with PRRs to enhance interferon production and antiviral effect.
Our overarching hypothesis for this proposal is that composition, assembly and disassembly of avSG
change during viral infection to allow host cells to respond and clear infection by limiting damage. In
preliminary studies we show that activation of RNase L induces avSG formation marked by SG protein, G3BP1
and contain antiviral proteins Rig-I, PKR, OAS and RNase L. We developed a novel method to purify avSG
and biochemically characterized protein-protein interactions in avSG that will be used in this proposal. We will
test our central hypothesis with the following specific aims. Aim 1: To determine stress-specific differences in
SG composition in canonical SG and avSG, Aim 2: To determine the physiological role of dynamic change in
avSG composition in virus infections. Completion of these aims will allow us to build on the advances in
purifying avSG to dissect the antiviral role of SG by following the dynamics of assembly or disassembly and
analyzing the avSG composition to provide correlation of stress response pathways and innate signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of small RNAs in innate immunity and inflammation
-
批准号:7939177
-
项目类别:
-
资助金额:$42.97万
-
财政年份:2010
-
负责人:Malathi Krishnamurthy
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: